Paclitaxel

Form: Injection (IV administration)

Strength: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL

Reference Brands: Taxol®, Abraxane® (US & EU)

Category: Oncology Cancer Care

Paclitaxel, marketed as Taxol® and Abraxane®, is a critical chemotherapy agent used to treat various cancers, including ovarian, breast, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel works by stabilizing microtubules to prevent cell division. Widely sourced by B2B pharmaceutical suppliers globally, Paclitaxel ensures GMP-compliant manufacturing and reliable supply to hospitals and oncology centers in the US and EU. With competitive pricing, it is a vital component in cancer treatment regimens, providing effective therapy for aggressive cancers.